A phase II study of the continuous intravenous infusion of interleukin-6 for metastatic renal cell carcinoma.
University of Texas Health Science Center at San Antonio, Division of Medical Oncology 78284-7884, USA.
G R
GR
Weiss
K A
KA
Margolin
M
M
Sznol
M B
MB
Atkins
L
L
Oleksowicz
R
R
Isaacs
J A
JA
Sosman
J H
JH
Doroshow
E G
EG
Trehu
J P
JP
Dutcher
D000328:Adult; D000368:Aged; D002292:Carcinoma, Renal Cell / Q000150:complications / Q000628:therapy*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D015850:Interleukin-6 / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000150:complications / Q000628:therapy*; D008175:Lung Neoplasms / Q000556:secondary / Q000628:therapy; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D012983:Soft Tissue Neoplasms / Q000556:secondary / Q000628:therapy
D015850:Interleukin-6